Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chun-meng Yao"'
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 16, Iss 1, Pp 1-10 (2024)
Abstract Aims To estimate the effects of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) on proteinuria and oxidative stress expression in type 2 diabetes patients. Materials and methods 68 patients with type 2 diabetes mellitus (T2DM) were div
Externí odkaz:
https://doaj.org/article/7e377515f7fa40b98f0b5f6a3f77708e
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract To evaluate the effect of SGLT2 inhibitor (SGLT2i) on albuminuria, nephrin (NPH) and transforming-growth-factor-beta1 (TGF-β1) levels in urine and low-grade inflammation in type 2 diabetes (T2D) patients. A randomized, blank-controlled clin
Externí odkaz:
https://doaj.org/article/6a9a9fc985664195b6072b9188d50559
Publikováno v:
Scientific reports. 12(1)
Objective: To evaluate the effect of SGLT2 inhibitor (SGLT2i) on albuminuria, nephrin (NPH) and transforming-growth-factor-beta1 (TGF-β1) levels in urine and low-grade inflammation in type 2 diabetes (T2D ) patients.Methods: A randomized, blank-cont
Objective: To evaluate the effect of SGLT2 inhibitor (SGLT2i) on albuminuria, nephrin(NPH) and transforming-growth-factor-beta1(TGF-β1) expression in urine, glucose and lipid metabolism, low grade inflammation in type 2 diabetes(T2D ) patients.Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::929ae203fb246f5cc07158f1cf600fa9
https://doi.org/10.21203/rs.3.rs-1581753/v1
https://doi.org/10.21203/rs.3.rs-1581753/v1